
Former president Bill Clinton announced agreements with drug companies Tuesday to lower the price of so-called second-line AIDS drugs for people in the developing world and to make a once-a-day AIDS pill available for less than $1 a day. The second-line antiretroviral drugs—needed by patients who develop resistance to first-line treatment—currently cost 10 times as much as first-line therapy, Clinton said. Nearly half a million patients will require these drugs by 2010.
Clinton's foundation negotiated agreements with generic drug makers Cipla Ltd. and Matrix Laboratories Ltd. that he said would mean an average savings of 25% in low-income countries and 50% in middle-income countries. He said the companies collaborated with the foundation to lower production costs, in part by securing lower prices for raw materials.
The reduced-price, once-daily pill combines the drugs tenofovir, lamivudine, and efavirenz.
Clinton said the new price of $339 per patient per year would be 45% lower than the current rate available to low-income countries and 67% less than the price available to many middle-income countries.
''Seven million people in the developing world are in need of treatment for HIV/AIDS,'' Clinton said. ''We are trying to meet that need with the best medicine available today, and at prices that low- and middle-income countries can afford.''
The Clinton Foundation's activities are being financed by UNITAID, an organization formed by France and 19 other nations that have earmarked a small portion of their airline tax revenues for HIV/AIDS programs in developing countries. UNITAID will provide the foundation with more than $100 million to buy second-line medicines for 27 countries through 2008.
''Every person living with HIV deserves access to the most effective medicines, and UNITAID aims to ensure that these are affordable for all developing countries,'' French foreign minister Philippe Douste-Blazy, chairman of UNITAID's board, said in a statement.
Since starting its HIV/AIDS Initiative in 2002, the Clinton Foundation has worked with 25 countries in Africa, the Caribbean, and Asia to set up AIDS treatment and prevention programs.The foundation also provides access to lower-priced AIDS drugs in 65 countries. Some 750,000 people are now receiving AIDS drugs purchased through the Clinton Foundation. (AP)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.